43rd Annual J.P. Morgan Healthcare Conference 2025
Logotype for Neogen Corporation

Neogen (NEOG) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for Neogen Corporation

43rd Annual J.P. Morgan Healthcare Conference 2025 summary

10 Jan, 2026

Business overview and strategy

  • Focused on global food security and safety through a broad consumables portfolio, with presence in nearly 40 countries and leadership in food and animal safety solutions.

  • Operates two main segments: food safety (rapid diagnostics, allergen/toxin detection) and animal safety (disease prevention, genomics for herd optimization and companion animal care).

  • Over 95% of the portfolio consists of consumable products, providing recurring revenue and high customer retention.

  • Product innovation, regional expansion, and tailored strategies in under-penetrated markets are key growth drivers.

  • Recent 3M transaction expanded workforce, product offerings, and added Petrifilm, a leading rapid indicator testing platform.

Market trends and regulatory environment

  • Food safety is increasingly topical due to new regulations, food allergy prevalence, and high-profile outbreaks.

  • USDA has expanded oversight, declaring Salmonella an adulterant in more poultry products and increasing focus on ready-to-eat foods.

  • Regulatory momentum is expected to continue, with more stringent requirements and consumer scrutiny.

  • Market fundamentals are strong, with food safety and animal safety markets estimated at $22B and $55B, and long-term growth rates of 6-8% and 4-6%.

  • Consumer preferences are shifting toward greater transparency and nutritional information.

Operational performance and integration

  • Food safety business grew 8% last quarter (excluding sample collection), despite industry-wide inflation and integration challenges.

  • Integration of 3M food safety business is nearly complete, with key manufacturing, back-office, and distribution transitions finished, and ERP implementation resolved.

  • New Petrifilm facility is operational, with full production expected in Q3 FY25.

  • End markets are stabilizing after 18 months of headwinds, with sequential improvement in customer sales.

  • Solutions span the entire food value chain, from raw materials to finished products, with dual applications in environmental and product testing.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more